Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy and Safety of KW-136 Capsule Combined With Sofosbuvir Tablet for Treatment of Adult Chronic Hepatitis C: an Open-label, Multi-center, Phase 3 Study

NCT03995485 is registered in ClinicalTrials.gov with Kawin Technology Share-holding Co., Ltd. as lead sponsor.

NCT NCT03995485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03995485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy and Safety of KW-136 Capsule Combined With Sofosbuvir Tablet for Treatment of Adult Chronic Hepatitis C: an Open-label, Multi-center, Phase 3 Study
Lead sponsor
Kawin Technology Share-holding Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
June 7, 2017
Completion date
March 7, 2018
Enrollment
371 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic